ABO-incompatibility does not influence the outcome after allogeneic hematopoietic stem cell transplantation with dose reduced-intensity conditioning

被引：0
|
作者：
Linck, D
Kraut, L
Pohl, H
Kiehl, M
Fauser, A
Basara, N
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [1] ABO-incompatibility in allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Passweg, JR
    Bucheli, E
    Hutter, A
    Halter, J
    Schanz, U
    Gratwohl, A
    Seebach, JD
    XENOTRANSPLANTATION, 2005, 12 (05) : 362 - 362
  • [2] ABO-incompatibility -: Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Muntwyler, J
    Passweg, J
    Seebach, L
    Schanz, U
    Gmür, J
    Gratwohl, A
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2002, 30 (02) : 87 - 93
  • [3] Major ABO-incompatibility, reduced-intensity conditioning regimens, and patient age are associated with prolonged red cell transfusion dependency after allogeneic haematopoietic stem cell transplantation
    Dahl, D.
    Koenecke, C.
    Heuft, H.
    Dammann, E.
    Stadler, M.
    Buchholz, S.
    Krauter, J.
    Eder, M.
    Sykora, K.
    Klein, C.
    Hahn, A.
    Ganser, A.
    Sauer, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S167 - S168
  • [4] Reassessment of ABO-incompatibility in hematopoietic stem cell transplantation
    Stussi, G
    Muntwyler, J
    Seebach, L
    Passweg, J
    Schanz, U
    Gratwohl, A
    Gmur, J
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2001, 27 : S75 - S75
  • [5] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Haefaa Alchalby
    Nicolaus Kröger
    Current Hematologic Malignancy Reports, 2010, 5 : 53 - 61
  • [6] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Alchalby, Haefaa
    Kroeger, Nicolaus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 53 - 61
  • [7] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [8] Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
    Watz, Emma
    Remberger, Mats
    Ringden, E.
    Lundahl, Joachim
    Ljungman, Per
    Mattsson, Jonas
    Wikman, Agneta
    Uhlin, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 264 - 271
  • [9] Excellent outcome of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with Sezary Syndrome
    Onida, F.
    Saporiti, G.
    Vincenti, D.
    Annaloro, C.
    Tagliaferri, E.
    Motta, B.
    Violetti, S. Alberti
    Berti, E.
    Cortelezzi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S281 - S282
  • [10] Impact of age on outcome after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning with Fludarabine/Busulfan
    Bethge, W. A.
    Federmann, B.
    Helwig, A.
    Faul, C.
    Vogel, W.
    Kanz, L.
    ONKOLOGIE, 2012, 35 : 129 - 129
12345